Evidence map›Paper›PMID 39009567›Full record

ArticleBlood cancer journal2024

Improved prevention and treatment strategies for differentiation syndrome contribute to reducing early mortality in patients with acute promyelocytic leukemia.

Qian Wu, Xiaofei Yang, Jingren Zhang, Mengxing Xue, Xueqing Dou, Zheng Ge, Yifei Chen, Weiying Gu, Weimin Dong, Hongying Cao and 13 more

Abstract readLetter
In one paragraph

Article in Blood cancer journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Qian Wu *National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China.ORCID 0009-0009-0254-7302
Xiaofei Yang *National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China.
Jingren ZhangNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China.
Mengxing XueNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China.
Xueqing DouNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China.
Zheng GeZhongda Hospital Southeast University, Nanjing, PR China.
Yifei ChenJiangdu People's Hospital of Yangzhou, Yangzhou, PR China.
Weiying GuThe First People's Hospital of Changzhou, Changzhou, PR China.ORCID 0000-0003-4913-1610
Weimin DongThe First People's Hospital of Changzhou, Changzhou, PR China.
Hongying CaoChangzhou No.2 People's Hospital, Changzhou, PR China.
Naike JiangChangzhou No.2 People's Hospital, Changzhou, PR China.
Xuemei SunJiangsu Province Hospital of Chinese Medicine, Nanjing, PR China.
Zefa LiuXinghua City People's Hospital, Taizhou, PR China.
Jinning ShiThe Affiliated Jiangning Hospital of Nanjing Medical University, Nanjing, PR China.
Hui ChenYancheng NO.1 People's Hospital, Yancheng, PR China.
Cixian ZhangXuzhou Central Hospital, Xuzhou, PR China.
Fengling MinAffiliated Hospital of Yangzhou University, Yangzhou, PR China.
Hongli SunWuxi People's Hospital, Wuxi, PR China.
Xiaoli QianTaizhou Second People's Hospital, Taizhou, PR China.
Hongjian YuanTaizhou Second People's Hospital, Taizhou, PR China.
Yuan FengZhenjiang First People's Hospital, Zhenjiang, PR China.
De-Pei WuNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China. drwudepei@163.com.ORCID 0000-0002-6312-3863
Suning ChenNational Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, PR China. chensuning@sina.com.ORCID 0000-0002-2967-3597

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, Promyelocytic, AcuteAdolescentAdultAgedCell DifferentiationFemaleHumansMaleMiddle AgedYoung Adult

Identifiers

PMID39009567
PMCPMC11251030

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.